Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,774.42
(
0.68%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 177254

Thursday, 04/24/2014 2:08:03 PM

Thursday, April 24, 2014 2:08:03 PM

Post# of 257302
If GILD were to lose its mind by pricing sofo/ledi 8-week at $100,000, 12-week at $150,000, there would be much bigger selloff in biotech than we just had. It would bring sustainability of drug price to near term rather than intermediate to long term. On the other hand, it would give ABBV/ENTA even better opportunity pricing wise.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today